BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 23177794)

  • 1. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.
    Picarelli A; Di Tola M; Marino M; Libanori V; Borghini R; Salvi E; Donato G; Vitolo D; Tiberti A; Marcheggiano A; Bassotti G; Corazziari E
    Transl Res; 2013 Mar; 161(3):172-80. PubMed ID: 23177794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of serological tests in the diagnosis of celiac disease].
    Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
    Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease.
    Alessio MG; Tonutti E; Brusca I; Radice A; Licini L; Sonzogni A; Florena A; Schiaffino E; Marus W; Sulfaro S; Villalta D;
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):44-9. PubMed ID: 22197946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiendomysium antibodies assay in the culture medium of intestinal mucosa: an accurate method for celiac disease diagnosis.
    Carroccio A; Iacono G; Di Prima L; Pirrone G; Cavataio F; Ambrosiano G; Sciumè C; Geraci G; Florena A; Teresi S; Barbaria F; Pepe I; Campisi G; Mansueto P; Soresi M; Di Fede G
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1018-23. PubMed ID: 21885984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
    Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
    Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
    Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
    J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis.
    Carroccio A; Di Prima L; Pirrone G; Scalici C; Florena AM; Gasparin M; Tolazzi G; Gucciardi A; Sciumè C; Iacono G
    Clin Chem; 2006 Jun; 52(6):1175-80. PubMed ID: 16574764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
    Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
    Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease.
    Tursi A; Brandimarte G; Giorgetti GM
    J Clin Gastroenterol; 2003; 37(5):387-91. PubMed ID: 14564185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.
    Tuire I; Marja-Leena L; Teea S; Katri H; Jukka P; Päivi S; Heini H; Markku M; Pekka C; Katri K
    Am J Gastroenterol; 2012 Oct; 107(10):1563-9. PubMed ID: 22825364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios.
    Picarelli A; Borghini R; Donato G; Di Tola M; Boccabella C; Isonne C; Giordano M; Di Cristofano C; Romeo F; Di Cioccio G; Marcheggiano A; Villanacci V; Tiberti A
    Scand J Gastroenterol; 2014 Nov; 49(11):1318-24. PubMed ID: 25113634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
    Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease.
    Kurppa K; Paavola A; Collin P; Sievänen H; Laurila K; Huhtala H; Saavalainen P; Mäki M; Kaukinen K
    Gastroenterology; 2014 Sep; 147(3):610-617.e1. PubMed ID: 24837306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
    Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
    Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
    Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care testing for celiac disease has a low sensitivity in endoscopy.
    Mooney PD; Kurien M; Evans KE; Chalkiadakis I; Hale MF; Kannan MZ; Courtice V; Johnston AJ; Irvine AJ; Hadjivassiliou M; Sanders DS
    Gastrointest Endosc; 2014 Sep; 80(3):456-62. PubMed ID: 24685008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
    Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
    Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease.
    Donaldson MR; Firth SD; Wimpee H; Leiferman KM; Zone JJ; Horsley W; O'Gorman MA; Jackson WD; Neuhausen SL; Hull CM; Book LS
    Clin Gastroenterol Hepatol; 2007 May; 5(5):567-73. PubMed ID: 17428743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
    Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
    Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.